Somapacitan
SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS
Also known as: NN8640, NNC0195-0092, sogroya, somapacitan (genetical recombination), somapacitan-beco
Data last refreshed: (DrugCentral release 2024-11-01)
Key facts
Somapacitan is a drug catalogued in DrugCentral. It was first approved by the FDA in 2020. DrugCentral lists 1 molecular target, including GHR. Recorded indications include Adult growth hormone deficiency.
- Molecular targets: GHR (1 listed in DrugCentral).
- Indications: Adult growth hormone deficiency.
- ATC code: H01AC07 (Somatropin and somatropin agonists).
Indications & contraindications
Drug–disease relationships curated by DrugCentral (OMOP / SNOMED concepts).
Indications (1)
- Adult growth hormone deficiency
Contraindications (2)
- Diabetic retinopathy
- Malignant neoplastic disease
Mechanism & targets
Molecular targets (1)
| Target | Gene | Action | Activity |
|---|---|---|---|
| Growth hormone receptor | GHR | unknown | Kd 8.04 |
Regulatory approvals (3)
| Date | Agency | Marketed as | Applicant | Orphan |
|---|---|---|---|---|
| 2023-06-26 | PMDA | — | Novo Nordisk Pharma Ltd. | |
| 2021-03-31 | EMA | — | Novo Nordisk A/S | |
| 2020-08-28 | FDA | — | NOVO NORDISK INC |
ATC classification
| ATC code | Therapeutic hierarchy |
|---|---|
H01AC07 | SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS › PITUITARY AND HYPOTHALAMIC HORMONES AND ANALOGUES › ANTERIOR PITUITARY LOBE HORMONES AND ANALOGUES › Somatropin and somatropin agonists |
Chemical structure
| Molecular formula | — |
|---|---|
| Molecular weight | — |
| CAS number | 1338578-34-9 |
| InChIKey | — |
| PubChem CID | 129894493 |
Frequently asked questions
Answers are generated from the structured data on this page, not written by hand.
What is Somapacitan used for?
DrugCentral lists the following indications for Somapacitan: Adult growth hormone deficiency.
How does Somapacitan work?
Its molecular targets in DrugCentral include GHR.
When was Somapacitan first approved?
Somapacitan was first approved by the FDA in 2020.
Browse: all drugs starting with S · drug guides by category · protein targets A–Z.
Sources
- DrugCentral drug card 5413 — structure, indications, targets, approvals, pharmacologic classes (CC BY-SA 4.0)
- ChEMBL CHEMBL3707290 — compound record and bioactivity
- PubChem CID 129894493 — chemical identifiers
- DrugBank DB15093 — drug record
- FDA UNII 8FOJ430U94 — substance identity
- DailyMed: FDA labels for Somapacitan — current prescribing information (label search)
- UniProt P10912 (GHR) — target protein
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.